What it sells
Empowering every doctor and every patient to participate in research
Business model breakdown
Buyer: who owns the budget?
Trial sponsors and trial sites pay; physician practices use it free.
Trigger: what makes them buy now?
Trial sites need qualified referrals; doctors want to offer patients new treatments.
Workflow: what inputs become what output?
Practices flag relevant patients, Novelcare sends study info and schedules screening.
Economics: what it saves and how it charges
Sites pay only per randomization; free for most practices, which may earn chart-review revenue.
Distribution: how it reaches customers
Sign-up and meeting booking; free if invited by a sponsor.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2023 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.